These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line. Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737 [TBL] [Abstract][Full Text] [Related]
47. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436 [TBL] [Abstract][Full Text] [Related]
48. Cellular induction mechanism of CD8+ suppressor T cells by DMBA and TPA: formation of CD4+ suppressor-inducer T cells. Negoro T; Iinuma F; Watanabe M Cell Immunol; 1996 Feb; 167(2):216-23. PubMed ID: 8603430 [TBL] [Abstract][Full Text] [Related]
49. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. Disis ML; Grabstein KH; Sleath PR; Cheever MA Clin Cancer Res; 1999 Jun; 5(6):1289-97. PubMed ID: 10389911 [TBL] [Abstract][Full Text] [Related]
50. [Effects of Angelica sinensis polysaccharide on cell-mediated immunity]. Yang TH; Jia M; Mei QB Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):782-3, 788. PubMed ID: 16256045 [TBL] [Abstract][Full Text] [Related]
51. Active immunotherapy with B.C.G. for recurrent malignant melanoma. Gutterman JU; Mavligit G; McBride C; Frei E; Freireich EJ; Hersh EM Lancet; 1973 Jun; 1(7814):1208-12. PubMed ID: 4122562 [No Abstract] [Full Text] [Related]
52. Immunotherapy in patients with melanoma. Seiger HF; Shingleton WW; Metzgar RS; Buckley CE Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702 [No Abstract] [Full Text] [Related]
53. Heterogeneity of melanoma-associated antigens detected by sera from patients receiving adjuvant allogeneic tumor vaccine immunotherapy. Dent PB; McCulloch PB; Liao SK; Stone BR; Singal DP Clin Immunol Immunopathol; 1982 May; 23(2):379-91. PubMed ID: 6980756 [No Abstract] [Full Text] [Related]
54. [Cutaneous, cellular immunity in malignant melanoma]. Kehrer HC Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233 [No Abstract] [Full Text] [Related]